Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Metformin: Prevention of Genomic Instability and Cancer: A Review Publisher Pubmed



Najafi M1 ; Cheki M2 ; Rezapoor S3 ; Geraily G4 ; Motevaseli E5 ; Carnovale C6 ; Clementi E7, 8 ; Shirazi A4
Authors

Source: Mutation Research - Genetic Toxicology and Environmental Mutagenesis Published:2018


Abstract

The diabetes drug metformin can mitigate the genotoxic effects of cytotoxic agents and has been proposed to prevent or even cure certain cancers. Metformin reduces DNA damage by mechanisms that are only incompletely understood. Metformin scavenges free radicals, including reactive oxygen species and nitric oxide, which are produced by genotoxicants such as ionizing or non-ionizing radiation, heavy metals, and chemotherapeutic agents. The drug may also increase the activities of antioxidant enzymes and inhibit NADPH oxidase, cyclooxygenase-2, and inducible nitric oxide synthase, thereby limiting macrophage recruitment and inflammatory responses. Metformin stimulates the DNA damage response (DDR) in the homologous end-joining, homologous recombination, and nucleotide excision repair pathways. This review focuses on the protective properties of metformin against genomic instability. © 2018 Elsevier B.V.
Other Related Docs
13. Metformin and Long Non-Coding Rnas in Breast Cancer, Journal of Translational Medicine (2023)